{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:15:12Z","timestamp":1778656512987,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>\n                    Since its description by Hull and colleagues in 1981, several case series have described the clinicopathological features of glycogen-rich breast carcinoma (GRC); however, no detailed genetic study has been performed. We identified 10 patients with GRC; all were female (ages: 32 to 74\u00a0y; median: 51). Tumor size ranged from 0.7 to 3.8\u00a0cm (median: 1.45). All except one GRC showed relatively well-defined borders, and all were composed predominantly of nests containing clear cells with glycogen accumulation in cytoplasm confirmed by Periodic Acid-Schiff\/Periodic Acid-Schiff- Diastase (PAS\/PAS-D)staining. Using Nottingham grading, four were grade 2 and six were grade 3. Seven showed associated ductal carcinoma in situ (DCIS) with glycogen-rich features. Lymph node macrometastasis was seen in 2=two. Six were hormone receptor (HR) +\/ human epidermal growth factor receptor 2 (HER2)\u2212, 2 HR low +\/ HER2\u2212 and 2 triple-negative. Follow-up (available for 9\/10) ranged from 9 to 186 months (median: 38). All patients were alive; two patients had distant metastasis, one patient had local recurrence and six had no evidence of disease. DNA sequencing suggested two molecular subgroups:\n                    <jats:italic toggle=\"yes\">GATA3<\/jats:italic>\n                    -mutant GRCs (5\/10) with frequent\n                    <jats:italic toggle=\"yes\">RPKSB1<\/jats:italic>\n                    copy number gain (4\/5) and\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    -mutant GRCs (4\/10).\n                    <jats:italic toggle=\"yes\">GATA3<\/jats:italic>\n                    -mutant GRCs were mixed grade 2\/3, all were HR+ without distant metastasis while\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    -mutant GRCs were all grade 3, showed low +\/\u2212 HR, and 3\/4 patients showed distant metastasis\/local recurrence. p53 immunohistochemistry showed mutant-pattern staining in three\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    -mutant GRCs tested as opposed to wild-type pattern in five\n                    <jats:italic toggle=\"yes\">GATA3<\/jats:italic>\n                    -mutant GRCs. Molecular studies or p53 immunohistochemistry as a surrogate could be helpful to identify the\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    -mutant subgroup for closer follow-up and\/or more aggressive treatment.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002530","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:00:09Z","timestamp":1773208809000},"page":"599-607","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological and Molecular Features of Glycogen-Rich Breast Carcinoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Burcu","family":"Karadal-Ferrena","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Lindeman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed A.","family":"Hoda","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital"},{"name":"Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-553X","authenticated-orcid":false,"given":"Baris","family":"Boyraz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"pt 1","key":"R1-20260513","first-page":"319","article-title":"\u201cClear-cell\u201d change within duct and lobular epithelium of the human breast","volume":"17","author":"Barwick","year":"1982","journal-title":"Pathol Annu"},{"key":"R2-20260513","first-page":"108","article-title":"Invasive breast carcinoma of no special type. Breast Tumours (WHO Classification of Tumours). Lyon, France: World Health Organization-IARC","volume":"2","author":"Rakha","year":"2019"},{"key":"R3-20260513","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/1097-0142(19811101)48:9<2003::AID-CNCR2820480916>3.0.CO;2-Q","article-title":"Glycogen-rich clear cell carcinoma of the breast: a light and electron microscopic study","volume":"48","author":"Hull","year":"1981","journal-title":"Cancer"},{"key":"R4-20260513","first-page":"655","article-title":"Glycogen-rich clear cell carcinoma of the breast: a comprehensive review","volume":"28","author":"Vranic","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"R5-20260513","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/his.15453","article-title":"Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple-negative breast cancer","volume":"87","author":"Kim","year":"2025","journal-title":"Histopathology"},{"key":"R6-20260513","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0046-8177(85)80175-1","article-title":"Glycogen-rich, clear cell breast cancer: with comments concerning other clear cell variants","volume":"16","author":"Fisher","year":"1985","journal-title":"Hum Pathol"},{"key":"R7-20260513","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00000478-198608000-00005","article-title":"Glycogen-rich clear cell carcinomas of the breast. A clinicopathologic and ultrastructural study","volume":"10","author":"Hull","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R9-20260513","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/jcm8020246","article-title":"Clinical features, survival and prognostic factors of glycogen-rich clear cell carcinoma (GRCC) of the breast in the U.S. population","volume":"8","author":"Zhou","year":"2019","journal-title":"J Clin Med"},{"key":"R10-20260513","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/tbj.12231","article-title":"Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast","volume":"20","author":"Ma","year":"2014","journal-title":"Breast J"},{"key":"R11-20260513","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000325436","article-title":"Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast: review of 37 cases with histologic correlation","volume":"52","author":"Akbulut","year":"2008","journal-title":"Acta Cytol"},{"key":"R12-20260513","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2325\/jbcs.12.189","article-title":"Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast","volume":"12","author":"Kuroda","year":"2005","journal-title":"Breast Cancer Tokyo Jpn"},{"key":"R13-20260513","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/00000478-199508000-00005","article-title":"Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases","volume":"19","author":"Hayes","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R14-20260513","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0046-8177(91)90066-X","article-title":"Glycogen-rich clear-cell carcinoma of the breast: a clinicopathologic and flow cytometric study","volume":"22","author":"Toikkanen","year":"1991","journal-title":"Hum Pathol"},{"key":"R15-20260513","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"R16-20260513","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/cncr.28566","article-title":"GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival","volume":"120","author":"Jiang","year":"2014","journal-title":"Cancer"},{"key":"R17-20260513","doi-asserted-by":"crossref","first-page":"103415","DOI":"10.18632\/oncotarget.21910","article-title":"GATA3 frameshift mutation promotes tumor growth in human luminal breast cancer cells and induces transcriptional changes seen in primary GATA3 mutant breast cancers","volume":"8","author":"Gustin","year":"2017","journal-title":"Oncotarget"},{"key":"R18-20260513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.011","article-title":"GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors","volume":"26","author":"Yang","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"R19-20260513","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anndiagpath.2014.12.001","article-title":"GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin","volume":"19","author":"Wendroth","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R20-20260513","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4161\/cc.21194","article-title":"The role of S6K1 in ER-positive breast cancer","volume":"11","author":"Holz","year":"2012","journal-title":"Cell Cycle Georget Tex"},{"issue":"suppl 2","key":"R21-20260513","first-page":"263","article-title":"Molecular profiling of clear cell carcinoma of the breast reveals novel targetable biomarkers","volume":"33","author":"Skenderi","year":"2020","journal-title":"Mod Pathol"},{"key":"R22-20260513","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jcem-39-3-443","article-title":"Ultrastructure of the human mammary gland. I. Development of the fetal gland throughout gestation","volume":"39","author":"Tobon","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20260513","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00000478-199804000-00003","article-title":"Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms","volume":"22","author":"Nakatani","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R24-20260513","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/his.13021","article-title":"Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours","volume":"69","author":"McNamee","year":"2016","journal-title":"Histopathology"},{"key":"R25-20260513","first-page":"1989","article-title":"Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation","volume":"33","author":"Skala","year":"2020","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"R26-20260513","first-page":"100829","article-title":"Extragonadal urinary tract neoplasms with yolk sac differentiation: clinical, histologic, and molecular evidence of derivation from underlying urothelial carcinoma","volume":"38","author":"Beauchamp","year":"2025","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"R27-20260513","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/PAS.0000000000001744","article-title":"Morphologic, immunohistochemical, and genetic differences between high-grade and low-grade fetal adenocarcinomas of the lung","volume":"45","author":"Li","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R28-20260513","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.21037\/jtd.2017.07.14","article-title":"Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study","volume":"9","author":"Zhang","year":"2017","journal-title":"J Thorac Dis"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:00:10Z","timestamp":1778655610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002530","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}